The -1021C->T DBH gene variant is not associated with epilepsy or antiepileptic drug response.

Published

Journal Article

Dopamine beta-hydroxylase (DBH) catalyzes the conversion of dopamine to norepinephrine (NE). Animal studies show that genes in the NE pathway are candidates for susceptibility to epilepsy and antiepileptic drug (AED) response. The authors genotyped the -1021C-->T major functional polymorphism in the DBH gene in 675 patients with epilepsy and 1,087 controls. The authors found no association with epilepsy, several epilepsy subtypes, or AED response. The results suggest that the -1021C-->T variant does not contribute to epilepsy.

Full Text

Cited Authors

  • Depondt, C; Cock, HR; Healy, DG; Burley, MW; Weinshenker, D; Wood, NW; Goldstein, DB; Sisodiya, SM

Published Date

  • October 2004

Published In

Volume / Issue

  • 63 / 8

Start / End Page

  • 1497 - 1499

PubMed ID

  • 15505174

Pubmed Central ID

  • 15505174

Electronic International Standard Serial Number (EISSN)

  • 1526-632X

International Standard Serial Number (ISSN)

  • 0028-3878

Digital Object Identifier (DOI)

  • 10.1212/01.wnl.0000142092.16719.ad

Language

  • eng